1. Home
  2. AMCX vs BCYC Comparison

AMCX vs BCYC Comparison

Compare AMCX & BCYC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo AMC Networks Inc.

AMCX

AMC Networks Inc.

HOLD

Current Price

$7.92

Market Cap

319.9M

ML Signal

HOLD

Logo Bicycle Therapeutics plc

BCYC

Bicycle Therapeutics plc

HOLD

Current Price

$5.12

Market Cap

360.7M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
AMCX
BCYC
Founded
1980
2009
Country
United States
United Kingdom
Employees
N/A
N/A
Industry
Cable & Other Pay Television Services
Biotechnology: Pharmaceutical Preparations
Sector
Telecommunications
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
319.9M
360.7M
IPO Year
2011
2019

Fundamental Metrics

Financial Performance
Metric
AMCX
BCYC
Price
$7.92
$5.12
Analyst Decision
Sell
Buy
Analyst Count
5
10
Target Price
$7.00
$13.90
AVG Volume (30 Days)
331.2K
593.0K
Earning Date
05-08-2026
04-30-2026
Dividend Yield
N/A
N/A
EPS Growth
132.55
N/A
EPS
1.66
N/A
Revenue
$2,311,801,000.00
N/A
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
$4.63
N/A
Revenue Growth
N/A
N/A
52 Week Low
$5.41
$4.24
52 Week High
$10.28
$9.55

Technical Indicators

Market Signals
Indicator
AMCX
BCYC
Relative Strength Index (RSI) 64.33 54.09
Support Level $7.77 $5.03
Resistance Level $8.19 $5.90
Average True Range (ATR) 0.30 0.24
MACD 0.13 0.08
Stochastic Oscillator 99.32 77.48

Price Performance

Historical Comparison
AMCX
BCYC

About AMCX AMC Networks Inc.

AMC Networks owns several linear TV networks, including AMC, WE tv, BBC America, IFC, and SundanceTV. AMC, its most widely distributed network,reached 55 million pay TV households in the US at the end of 2025. The firm also had nearly 10.5 million US streaming subscribers, with AMC+ as the flagship streaming platform. With both its linear networks and streaming offerings, the firm caters to specific niche audiences. Over the last 15 years, AMC has shifted its focus to original scripted programming from classic movies. It creates content through AMC Studios and also generates revenue from licensing content. Following an international divestiture at the end of 2023, domestic operations make up nearly 90% of total revenue.

About BCYC Bicycle Therapeutics plc

Bicycle Therapeutics PLC is a clinical-stage biopharmaceutical company developing a novel class of medicines which are referred to as Bicycles. The Bicycles are synthetic short peptides constrained to form two loops that stabilize their structural geometry. Its initial internal programs are focused on oncology indications with high unmet medical needs. The company's product candidate, BT1718, is a Bicycle Toxin Conjugate, or BTC. The company has two segments: the United Kingdom and the United States. It derives maximum revenue from United States.

Share on Social Networks: